PNC Financial Services Group Inc. raised its position in shares of Agilent Technologies, Inc. (NYSE:A) by 720.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,131,276 shares of the medical research company’s stock after purchasing an additional 993,414 shares during the period. PNC Financial Services Group Inc. owned 0.35% of Agilent Technologies worth $67,097,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Jennison Associates LLC purchased a new stake in shares of Agilent Technologies during the 2nd quarter worth about $212,000. Skandinaviska Enskilda Banken AB publ raised its stake in shares of Agilent Technologies by 5.7% during the 1st quarter. Skandinaviska Enskilda Banken AB publ now owns 64,834 shares of the medical research company’s stock worth $3,428,000 after purchasing an additional 3,489 shares in the last quarter. Commerce Bank purchased a new stake in shares of Agilent Technologies during the 2nd quarter worth about $1,242,000. Delta Lloyd Asset Management N.V. purchased a new stake in shares of Agilent Technologies during the 2nd quarter worth about $2,026,000. Finally, Cipher Capital LP raised its stake in shares of Agilent Technologies by 18.1% during the 2nd quarter. Cipher Capital LP now owns 89,523 shares of the medical research company’s stock worth $5,309,000 after purchasing an additional 13,703 shares in the last quarter.
In other Agilent Technologies news, insider Mark Doak sold 12,421 shares of the company’s stock in a transaction that occurred on Friday, August 18th. The stock was sold at an average price of $61.57, for a total value of $764,760.97. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Patrick Kaltenbach sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, July 13th. The shares were sold at an average price of $61.26, for a total value of $306,300.00. Following the completion of the sale, the insider now owns 45,138 shares in the company, valued at approximately $2,765,153.88. The disclosure for this sale can be found here. Insiders have sold 155,165 shares of company stock valued at $9,768,409 over the last three months.
Shares of Agilent Technologies, Inc. (A) traded up 0.43% on Friday, reaching $65.96. The company’s stock had a trading volume of 2,295,974 shares. Agilent Technologies, Inc. has a 1-year low of $42.92 and a 1-year high of $66.42. The company’s 50 day moving average is $62.40 and its 200-day moving average is $58.01. The firm has a market cap of $21.23 billion, a price-to-earnings ratio of 34.02 and a beta of 1.30.
Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Tuesday, August 15th. The medical research company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.52 by $0.07. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. The firm had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.09 billion. During the same period in the prior year, the firm posted $0.49 earnings per share. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. Equities research analysts expect that Agilent Technologies, Inc. will post $2.32 EPS for the current year.
ILLEGAL ACTIVITY WARNING: This article was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://ledgergazette.com/2017/09/17/pnc-financial-services-group-inc-purchases-993414-shares-of-agilent-technologies-inc-a.html.
A number of equities research analysts have recently weighed in on the company. Wells Fargo & Company raised Agilent Technologies from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $42.92 to $60.73 in a research note on Wednesday, July 12th. BidaskClub raised Agilent Technologies from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, July 11th. Deutsche Bank AG set a $68.00 price target on Agilent Technologies and gave the stock a “buy” rating in a research note on Wednesday, August 16th. Robert W. Baird raised their price target on Agilent Technologies from $57.00 to $62.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 24th. Finally, J P Morgan Chase & Co reaffirmed an “overweight” rating and set a $70.00 price target on shares of Agilent Technologies in a research note on Wednesday, August 16th. Three research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Agilent Technologies has a consensus rating of “Buy” and a consensus price target of $63.91.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.